Valuation Alfresa Holdings Corporation

Stocks

Delayed Japan Exchange 20:17:19 2026-10-14 EDT			5-day change	1st Jan Change
2,287.00 ^JPY	+0.57%		+2.19%	-5.86%

10-05	Healios Completes First 144 Million Yen Culture Supernatant Shipment to JENECEL	MT
06-30	Ember LifeSciences, Inc. announced that it has received funding from Alfresa Holdings Corporation	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	343,826	343,217	415,318	383,847	459,384	398,890	-	-
Change	-	-0.18%	21.01%	-7.58%	19.68%	-13.17%	-	-
Enterprise Value (EV)	168,429	186,950	236,499	242,307	301,938	398,890	398,890	398,890
Change	-	11%	26.5%	2.46%	24.61%	32.11%	0%	0%
P/E	11.1x	13.3x	14.4x	14.3x	11x	17.2x	14.5x	15.1x
PBR	0.73x	0.7x	0.87x	0.8x	0.91x	0.8x	0.76x	0.76x
PEG	-	-0.8x	0.7x	-3.34x	0.2x	-0.4x	0.8x	-3.71x
Capitalization / Revenue	0.13x	0.13x	0.15x	0.13x	0.15x	0.12x	0.12x	0.12x
EV / Revenue	0x	0x	0x	0x	0x	0.12x	0.12x	0.12x
EV / EBITDA	0x	0x	0x	0x	0x	7.73x	7.64x	7.6x
EV / EBIT	0x	0x	0x	0x	0x	11.6x	10.8x	10.5x
EV / FCF	0x	-0x	0x	-0x	0x	19x	24.4x	33.2x
FCF Yield	11.3%	-2.17%	17.4%	-4.12%	6.5%	5.26%	4.1%	3.01%
Dividend per Share ²	54	57	70	63	68	71	79.67	85
Rate of return	3.18%	3.36%	3.15%	2.98%	2.69%	3.12%	3.5%	3.74%
EPS ²	153.6	127.4	154.1	147.5	229.6	132.4	157	150.6
Distribution rate	35.2%	44.7%	45.4%	42.7%	29.6%	53.6%	50.8%	56.5%
Net sales ¹	2,585,643	2,696,069	2,858,500	2,961,051	3,104,064	3,193,819	3,288,778	3,340,075
EBITDA ¹	41,915	43,450	51,974	58,607	51,212	51,628	52,221	52,514
EBIT ¹	29,091	30,148	38,460	38,080	36,164	34,398	36,942	38,069
Net income ¹	32,182	25,786	29,558	27,389	41,746	23,414	27,149	26,886
Net Debt	-175,397	-156,267	-178,819	-141,540	-157,446	-	-	-
Reference price ²	1,699.00	1,696.00	2,222.50	2,111.50	2,528.00	2,274.00	2,274.00	2,274.00
Nbr of stocks (in thousands)	202,370	202,369	186,870	181,789	181,719	175,413	-	-
Announcement Date	5/16/22	5/15/23	5/14/24	5/15/25	5/15/26	-	-	-

¹JPY in Million²JPY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ALFRESA HOLDINGS CORPORATION	17.21x	-	-	3.12%	2.52B
ABBOTT LABORATORIES	30.28x	4.01x	15.52x	2.5%	178B
MEDTRONIC PLC	19.91x	3.59x	12.87x	3.03%	119B
STRYKER CORPORATION	22x	4.32x	15.06x	1.27%	108B
ESSILORLUXOTTICA	25.91x	2.55x	10.24x	2.77%	75.27B
CENCORA, INC.	18.11x	0.21x	13.16x	0.72%	62.99B
HOYA CORPORATION	30.82x	7.66x	19.72x	1.3%	53.46B
BECTON, DICKINSON AND COMPANY	36.11x	3.47x	11.89x	2.09%	51.04B
IDEXX LABORATORIES, INC.	35.24x	8.76x	24.54x	-.--%	40.99B
DEXCOM, INC.	34.18x	5.99x	18.81x	-.--%	32.1B
Average	26.98x	4.51x	15.76x	1.68%	72.33B
Weighted average by Cap.	26.68x	4.09x	14.97x	1.91%